Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02700646 · ClinicalTrials.gov registry record · NA

Improving Motor Skill Development in Infants After Cardiac Surgery

A NA study of Congenital Heart Disease, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT02700646: Completed NA study of Congenital Heart Disease, sponsored by University of Michigan.

NCT02700646 is a NA study of Congenital Heart Disease that has completed, run by University of Michigan. The registered enrollment target is 65 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02700646, a NA study of Congenital Heart Disease, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn more about developmental behaviors and to examine changes in developmental progress related to motor activities among a group of infants who received open heart surgery within the first three months of life.

Primary Outcome

Alberta Infant Motor Scale (AIMS) score

Conditions Studied

Interventions

  • BEHAVIORAL Standard care
  • BEHAVIORAL Developmental recommendations

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2016-01-05
Est. Completion 2019-05-13
Phase NA
University of Michigan

1,327 total trials

What the finished NCT02700646 record still lists

NCT02700646 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.

NCT02700646 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02700646 about?

NCT02700646 is a clinical study titled "Improving Motor Skill Development in Infants After Cardiac Surgery". The purpose of this study is to learn more about developmental behaviors and to examine changes in developmental progress related to motor activities among a group of infants who received open heart surgery within the first three months of life.

What is the current status of trial NCT02700646?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2016-01-05. Estimated completion is 2019-05-13.

What conditions does trial NCT02700646 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

What interventions are being tested in trial NCT02700646?

The interventions under investigation include: Standard care (BEHAVIORAL), Developmental recommendations (BEHAVIORAL).

Who is sponsoring clinical trial NCT02700646?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02700646 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02700646's enrollment target sits among peer trials

65 35th of 63 higher than 29 of 63 other Congenital Heart Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02700646, the US trial registry maintained by the National Library of Medicine. NCT02700646 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.